Evidence map›Paper›PMID 34953062›Full record

ArticleESC heart failure2022

Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.

Valéry Legris, Bernard Thibault, Jocelyn Dupuis, Michel White, Anita W Asgar, Annik Fortier, Céline Pitre, Nadia Bouabdallaoui, Christine Henri, Eileen O'Meara and 2 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Valéry LegrisDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Bernard ThibaultDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Jocelyn DupuisDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Michel WhiteDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Anita W AsgarDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Annik FortierMontreal Health Institute Coordinating Center (MHICC), Montreal, Quebec, Canada.
Céline PitreDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Nadia BouabdallaouiDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Christine HenriDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Eileen O'MearaDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Anique DucharmeDepartment of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
EARTH Investigators
Montreal Heart Institute · CAUniversité de Montréal · CAThe Coordinating Center · US

Funding

CIHR 67914
6 · The paper itself

Abstract

aimsRight ventricular (RV) dysfunction, pulmonary hypertension, and exercise intolerance have prognostic values, but their interrelation is not fully understood. We investigated how RV function alone and its coupling with pulmonary circulation (RV-PA) predict cardio-respiratory fitness in patients with heart failure and reduced ejection fraction (HFrEF). METHODS AND

resultsThe Evaluation of Resynchronization Therapy for Heart Failure (EARTH) study included 205 HFrEF patients with narrow (n = 85) and prolonged (n = 120) QRS duration undergoing implantable cardioverter defibrillator implantation. All patients underwent a comprehensive evaluation with exercise tolerance tests and echocardiography. We investigated the correlations at baseline between RV parameters {size, function [tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RV-FAC), and RV myocardial performance index (RV-MPI)], pulmonary artery systolic pressure (PASP), and tricuspid regurgitation}; left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume index (LVEDVi), and left atrial volume index (LAVi); and cardiopulmonary exercise test (CPET) [peak VO

conclusionsRight ventricular function assessed by echocardiography (RV-MPI and RV-FAC) is closely associated with exercise tolerance in patients with HFrEF. When the TAPSE/PASP ratio is available, this marker of RV-PA coupling becomes the stronger echocardiographic predictor of exercise capacity in this population, highlighting its potential role as a screening tool to identify patients with reduced exercise capacity and potentially triage them to formal peak VO

Indexed as

Exercise ToleranceHeart Failure, SystolicAgedFemaleHumansMaleMiddle AgedPulmonary CirculationStroke VolumeVentricular Function, LeftVentricular Function, RightEchocardiographyExercise toleranceHeart failure with reduced ejection fractionRight ventricular functionRV to pulmonary arterial coupling

Identifiers

PMID34953062
PMCPMC8788036
OpenAlexW4200194016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.